Retrospective Study
Copyright ©The Author(s) 2023.
World J Methodol. Sep 20, 2023; 13(4): 248-258
Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.248
Table 2 Analysis of patient survival, baseline values and variables (mean ± SD)
Survival
Outpatient (n = 258)
Hospitalization (n = 117)
ICU (n = 69)
Mortality (n = 35)
P value
Baseline characteristics
    Age (yr)50.27 ± 10.6747.76 ± 11.0561.61 ± 7.56< 0.001
    Gender Female107 (41.5)47 (40.2)21 (30.4)12 (34.3)0.1281
Male151 (58.5)70 (59.8)48 (69.6)23 (65.7)
    Exposure time (h)3.90 ± 1.624.45 ± 1.685.19 ± 1.795.14 ± 1.78< 0.001
    COHb (%)23.98 ± 4.193238 ± 2.8138.49 ± 2.9945.26 ± 3.19< 0.001
    Troponin I (ng/mL)0.04 ± 0.090.33 ± 0.270.77 ± 0.211.35 ± 0.36< 0.001
    Lactate (mmol/L)1.42 ± 0.393.54 ± 0.954.34 ± 0.688.14 ± 0.63< 0.001
Patient groupsPre-pandemic198 (76.7)40 (34.2)10 (14.5)5 (14.3)< 0.0011
PandemicNon-COVID-1950 (19.4)26 (22.2)5 (7.2)2 (5.7)
Mild8 (3.1)28 (23.9)21 (30.4)3 (8.6)
Moderate2 (0.8)16 (13.7)17 (24.6)10 (28.6)
Severe07 (6)16 (23.2)15 (42.9)